UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Use of probiotics in gastrointestinal disorders: what to recommend?

Therapeutic Advances in Gastroenterology, 2010-09, Vol.3 (5), p.307-319

2010

Link zum Volltext

Verfügbarkeit prüfen

Evaluation and Treatment of Constipation in the Geriatric Population

Clinics in geriatric medicine, 2021-02, Vol.37 (1), p.85-102

2021

Link zum Volltext

Verfügbarkeit prüfen

Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice

Therapeutic Advances in Gastroenterology, 2017-02, Vol.10 (2), p.253-275

2017

Link zum Volltext

Verfügbarkeit prüfen

A Prospective Study of Physiological Parameters in Patients with Diarrhea Predominant IBS versus Patients with Constipation Predominant IBS versus Patients with Mixed Symptom IBS Using a Wireless Motility Capsule: 2748

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S1527-S1528

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials

Therapeutic advances in gastroenterology, 2019-04, Vol.12, p.1756284819841290-1756284819841290

2019

Link zum Volltext

Verfügbarkeit prüfen

Developing Valid and Reliable Health Utilities in Irritable Bowel Syndrome: Results From the IBS PROOF Cohort

The American journal of gastroenterology, 2009-06, Vol.104 (8), p.1984-1991

2009

Link zum Volltext

Verfügbarkeit prüfen

Optimizing outcomes with alosetron hydrochloride in severe diarrhea-predominant irritable bowel syndrome

Therapeutic advances in gastroenterology, 2010-05, Vol.3 (3), p.165-172

Lucak, Susan L

2010

Link zum Volltext

Verfügbarkeit prüfen

Irritable bowel syndrome and ischemic colitis: evidence supporting the increased use of alosetron

Therapeutic advances in gastroenterology, 2012-07, Vol.5 (4), p.215-218

Lucak, Susan

2012

Link zum Volltext

Verfügbarkeit prüfen

Do Patients Understand the Bristol Stool Scale? Results of Cognitive De-Briefing of IBS Patients

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-615-S-615

2011

Link zum Volltext

Verfügbarkeit prüfen

Factors Analysis of Bowel Symptoms in IBS: Guidance for Patient Reported Outcome (PRO) Development

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-605-S-606

2011

Link zum Volltext

Verfügbarkeit prüfen

865 Patient-Reported Symptom Relief From Current Therapy is a Robust Marker of Illness Severity in IBS

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-119-S-119

2010

Link zum Volltext

Verfügbarkeit prüfen

M1319 Do IBS Patients Understand the Difference Between Abdominal Pain vs. Discomfort? Implications for Clinical Practice and Clinical Trial Design

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-379-S-379

2010

Link zum Volltext

Verfügbarkeit prüfen

733 Characterizing Abdominal Pain Attributes in IBS: Guidance for Study Inclusion Criteria and Outcome Measurement

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-99-S-100

2010

Link zum Volltext

Verfügbarkeit prüfen

M1320 Characterizing “Bowel Urgency”: Guidance for Outcome Assessment in Patients With Diarrhea Predominant IBS

Gastroenterology (New York, N.Y. 1943), 2010, Vol.138 (5), p.S-379-S-379

2010

Link zum Volltext

Verfügbarkeit prüfen

Risk of Serious Adverse Events With Alosetron is Similar to or Less Than That Associated With Other Drugs Prescribed for Chronic GI Disorders: 1817

The American journal of gastroenterology, 2014-10, Vol.109, p.S537-S538

2014

Link zum Volltext

Verfügbarkeit prüfen

Review: Optimizing outcomes with alosetron hydrochloride in severe diarrhea-predominant irritable bowel syndrome

Therapeutic Advances in Gastroenterology, 2010-05, Vol.3 (3), p.165-172

Lucak, Susan L.

2010

Link zum Volltext

Verfügbarkeit prüfen

156 Euroqol Utilities Demonstrate Excellent Validity and Responsiveness in IBS: Results from the Proof Cohort

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-28-A-28

2008

Link zum Volltext

Verfügbarkeit prüfen

155 Predictors of Work Productivity in Irritable Bowel Syndrome (IBS): Results from the Proof Cohort

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-28-A-28

2008

Link zum Volltext

Verfügbarkeit prüfen

T1026 Measuring IBS Patient Reported Outcomes with a Single Item Numeric Rating Scale: Results from the PROOF Cohort

Gastroenterology (New York, N.Y. 1943), 2008, Vol.134 (4), p.A-467-A-467

2008

Link zum Volltext

Verfügbarkeit prüfen

An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder

Journal of clinical psychopharmacology, 2016-12, Vol.36 (6), p.710-715

2016

Link zum Volltext

Verfügbarkeit prüfen

Handbook of Gastroenterologic Procedures

Gastroenterology, 2006-02, Vol.130 (2), p.617-618

Lucak, Susan

2006

Link zum Volltext

Verfügbarkeit prüfen

Sa1594 - Patients with Ibs and Sibo have Lower Ileocecal Junction Pressures and Differences in Intestinal Transit Times as Compared to Ibs Patients without Sibo Using a Wireless Motility Capsule

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-324-S-324

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of Eluxadoline on Abdominal and Bowel Symptoms Over Time in Phase 3 Clinical Trials in Patients With Irritable Bowel Syndrome With Diarrhea: 1761

The American journal of gastroenterology, 2015-10, Vol.110, p.S748

2015

Link zum Volltext

Verfügbarkeit prüfen

Impact of Baseline Pain Severity on the Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea: 557

The American journal of gastroenterology, 2016-10, Vol.111, p.S254

2016

Link zum Volltext

Verfügbarkeit prüfen

Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort

The American journal of gastroenterology, 2009-08, Vol.104 (8), p.1984-1991

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Gastroenterology And Hepatology
(9)
Life Sciences & Biomedicine
(7)
Science & Technology
(7)
Irritable Bowel Syndrome
(6)
Gastroenterology & Hepatology
(4)
Humans
(4)
Female
(3)
Reviews
(3)
Adult
(2)
Biological And Medical Sciences
(2)
Constipation
(2)
Diarrhea
(2)
Efficacy
(2)
Irritable Bowel Syndrome - Complications
(2)
Irritable Bowel Syndrome - Diagnosis
(2)
Male
(2)
Medical Sciences
(2)
Middle Aged
(2)
5-Ht3 Antagonist
(1)
Abdominal Pain
(1)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of probiotics in gastrointestinal disorders: what to recommend?

Evaluation and Treatment of Constipation in the Geriatric Population

Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice

A Prospective Study of Physiological Parameters in Patients with Diarrhea Predominant IBS versus Patients with Constipation Predominant IBS versus Patients with Mixed Symptom IBS Using a Wireless Motility Capsule: 2748

Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials

Developing Valid and Reliable Health Utilities in Irritable Bowel Syndrome: Results From the IBS PROOF Cohort

Optimizing outcomes with alosetron hydrochloride in severe diarrhea-predominant irritable bowel syndrome

Irritable bowel syndrome and ischemic colitis: evidence supporting the increased use of alosetron

Do Patients Understand the Bristol Stool Scale? Results of Cognitive De-Briefing of IBS Patients

Factors Analysis of Bowel Symptoms in IBS: Guidance for Patient Reported Outcome (PRO) Development

865 Patient-Reported Symptom Relief From Current Therapy is a Robust Marker of Illness Severity in IBS

M1319 Do IBS Patients Understand the Difference Between Abdominal Pain vs. Discomfort? Implications for Clinical Practice and Clinical Trial Design

733 Characterizing Abdominal Pain Attributes in IBS: Guidance for Study Inclusion Criteria and Outcome Measurement

M1320 Characterizing “Bowel Urgency”: Guidance for Outcome Assessment in Patients With Diarrhea Predominant IBS

Risk of Serious Adverse Events With Alosetron is Similar to or Less Than That Associated With Other Drugs Prescribed for Chronic GI Disorders: 1817

Review: Optimizing outcomes with alosetron hydrochloride in severe diarrhea-predominant irritable bowel syndrome

156 Euroqol Utilities Demonstrate Excellent Validity and Responsiveness in IBS: Results from the Proof Cohort

155 Predictors of Work Productivity in Irritable Bowel Syndrome (IBS): Results from the Proof Cohort

T1026 Measuring IBS Patient Reported Outcomes with a Single Item Numeric Rating Scale: Results from the PROOF Cohort

An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder

Handbook of Gastroenterologic Procedures

Sa1594 - Patients with Ibs and Sibo have Lower Ileocecal Junction Pressures and Differences in Intestinal Transit Times as Compared to Ibs Patients without Sibo Using a Wireless Motility Capsule

Effect of Eluxadoline on Abdominal and Bowel Symptoms Over Time in Phase 3 Clinical Trials in Patients With Irritable Bowel Syndrome With Diarrhea: 1761

Impact of Baseline Pain Severity on the Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea: 557

Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort

Suchergebnisse filtern